The in vivo revolution: How Interius, Umoja, and Vyriad are transforming CAR-T cell therapy

Fecha de publicación: 10/01/2025
Fuente: Labiotech
Lugar: News and Trends
A U.S. trial of an in vivo CAR gene therapy has expanded to Europe, marking the first-ever trial of its kind in the region.
The post The in vivo revolution: How Interius, Umoja, and Vyriad are transforming CAR-T cell therapy appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.